-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632. Chronic Myeloid Leukemia: Therapy: Poster II

Chronic Myeloid Leukemia: Therapy Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Susanne Saussele1, Mareike Stein1*, Arthur Gil2*, Ute Kossak-Roth1*, Michael Lauseker, PhD2*, Ulrike Proetel1*, Hermann Einsele, MD3, Philippe Schafhausen4*, Elisabeth Lange5*, Mathias Hänel6*, Karsten Spiekermann, MD7, Martin Sökler, MD8*, Clemens Wendtner9*, Stephan Kremers10*, Michael Pfreundschuh11, Ernst Holler12*, Wolf-Karsten Hofmann1, Andreas Hochhaus, MD13, Martin C. Müller1*, Ruediger Hehlmann, MD1 and Markus Pfirrmann2*

1III. Medizinische Klinik, Universität Heidelberg, Medizinische Fakultät, Mannheim, Germany
2Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität, München, Germany
3Medizinischen Klinik und Poliklinik II, Universitätsklinikum, Würzburg, Germany
4II. Medizinische Klinik und Poliklinik, Universitätsklinikum Eppendorf, Hamburg, Germany
5Medizinische Klinik, Evangelisches Krankenhaus, Hamm, Germany
6Klinik für Innere Medizin III, Klinikum, Chemnitz, Germany
7Medizinische Klinik und Poliklinik III, Klinikum der Universität, München, Germany
8Department II of Internal Medicine, University Hospital, Tübingen, Germany
9Klinikum Schwabing, Städtisches Klinikum, München, Germany
10Abteilung Hämatologie und Onkologie, Caritaskrankenhaus, Lebach, Germany
11Klinik für Innere Medizin I, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany
12Abteilung für Hämatologie und internistische Onkologie, Universitätsklinikum, Regensburg, Germany
13Department of Hematology and Oncology, University Hospital Jena, Jena, Germany

Franck E. Nicolini, MD, PhD1,2,3, Marie Balsat, MD4*, Maud Lekieffre, MD1*, Vincent Alcazer, MD1*, Hélène Labussière-wallet, MD1*, Sarah Huet, PharmD, PhD5*, Sandrine Hayette2,6*, Stéphanie Dulucq, PharmD, PhD2,7*, Stéphane Morisset, Stat1*, Jeremy Ruby, CRA1,2*, Isabelle Tigaud, MD5*, Marie-Pierre Fort, CRA8*, Mael Heiblig, MD1*, Rémi Chapelon, CRA1*, Madeleine Etienne, CRA1,2*, Mohamad Sobh, PharmD1*, Francois-Xavier Mahon, MD, PhD, Professor2,8*, Mauricette Michallet, MD, PhD1,2 and Gabriel Etienne, MD, PhD2,8*

1Hematology department 1G, Centre Hospitalier Lyon Sud, Pierre Bénite, France
2Hôpital Haut Lévêque, Fi-LMC group, Pessac, France
3INSERM U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France
4Hematology department 1G, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
5Laboratory of Hematology, Centre Hospitalier Lyon Sud, Pierre Bénite, France
6Hematology Laboratory, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
7Laboratory of Hematology, Hôpital Haut Lévêque, Pessac, France
8Hematology department, Institut Bergonié, Bordeaux, France

Silvia Mori, PhD1*, Philipp le Coutre, MD2, Elisabetta Abruzzese, MD3,4, Bruno Martino, MD5*, Ester Pungolino, MD6*, Chiara Elena, MD7,8*, Ivana Pierri, MD9*, Sarit E. Assouline, MD MSc10, Anna D'Emilio, MD11*, Antonella Gozzini, MD12*, Pilar Giraldo, MD, PhD13, Fabio Stagno, MD, PhD14, Alessandra Iurlo, MD, PhD15*, Andrea Aroldi, MD16*, Michela Luciani, RN1*, Giulia De Riso, RN1*, Kim Dong-Wook, MD, PhD17*, Alessandra Pirola, MSc1*, Anna Petroccione18*, Maria Luisa Bonanomi18*, Patrizia Crivori, PhD18*, Rocco Piazza, MD, PhD1* and Carlo Gambacorti-Passerini, MD1,19

1Dept. of Health Sciences, University of Milano-Bicocca, Monza, Italy
2Hematology and Oncology, Charité, Humboldt University, Campus Virchow, Berlin, Berlin, Germany
3Tor Vergata University, Roma, Italy
4Hematology, S. Eugenio Hospital, Roma, Italy
5Hematology, Bianchi Melacrino Morelli Hospital, REggio Calabria, Italy
6Niguarda Cà Granda Hospital, Milan, Italy
7Dept. of Molecular Medicine, University of Pavia, Pavia, Italy
8Dept Oncology-Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
9Hematology Clinic, IRCSS AOU S.Martino-IST, University of Genova, Genova, Italy
10Jewish General Hospital, Montreal, QC, Canada
11Hematology, San Bortolo Hospital, Vicenza, Italy
12Hematology, AOU Careggi, University of Florence, Firenze, Italy
13Miguel Servet University Hospital and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Zaragoza, Spain
14Chair of Hematology, University of Catania, Catania, Italy
15Division of Hematology, IRCCS Maggiore Policlinico Hospital Foundation, Milano, Italy
16University of Milano-Bicocca, Monza, Italy
17Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, South Korea
18Clioss s.r.l., Nerviano, Italy
19Hematology and Clinical Research Unit, San Gerardo Hospital, Monza, Italy

Valentín García-Gutierrez1*, Maria Teresa Gómez Casares2*, Jimenez Velasco Antonio3*, Alonso Juan Manuel4*, Santiago Osorio5*, Juan Carlos Hernández-Boluda6*, Jose Manuel Puerta7*, Rosa Collado8*, Maria Jose Ramirez9*, Fatima Ibañez10*, María Luisa Martín Mateos10*, Juan Diego Rodriguez Gambarte11*, Carolina Martinez Laperche5*, Sara Redondo5*, Montse Gomez12*, DV Suarez Fiallo13*, Alicia Rodriguez Fernandez14*, Concepcion Ruiz15* and Juan Luis Steegmann, MD16

1Hematology Department, Hospital Ramón y Cajal, Madrid, Spain
2Hospital Universitario Doctor Negrin. Hematology department, Las Palmas de Gran Canaia, Spain
3Hospital Regional Universitario de Málaga, servicio de Hematología., Málaga, Spain
4Laboratorio Central Br Salud, Hospital Infanta Sofía, Madrid, Spain
5Hospital Universitario Gregorio Marañón. Servicio de Hematología, Madrid, Spain
6Hematology Department, Hospital Clínico, Valencia, Spain
7Unidad de Gestión Clínica Hematología y Hemoterapia, Hospital Universitario Virgen de las Nieves, Granada, Spain
8Laboratorio de Genética. Servicio de Hematología. Consorcio Hospital General Universitario, Valencia, Spain
9Department of Hematology, Hospital de Jerez de la Frontera, Jerez de la Frontera. Cádiz, Spain
10Servicio de Hematología. Hospital San Pedro de Alcántara.Servicio Extremeño de Salud, Caceres, Spain
11Hospital Universitario Ramón y Cajal. Hematology department, Madrid, Spain
12Hematology Department, Hospita Clinico, Valencia, Spain
13Hospital Universitario Doctor Negrin. Hematology department, Las Palmas de Gran Canaria, Spain
14Servicio de Hematologia, Hospital Virgen de la Macarena, Sevilla, Spain
15Hospital Regional Universitario de Málaga, servicio de Hematología., Malaga, Spain
16Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, Madrid, Spain

David T Yeung, BSc, MBBS, FRACP, FRCPA1,2,3, Wendy Tara Parker, PhD4*, Stuart Phillis, B Biotech5*, Jasmina Georgievski, BSc5*, Hamish S Scott, BSc, PhD, FFSc (RCPA)6,7, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA8 and Susan Branford, PhD FFSc (RCPA)3,6,9,10,11

1Haematology, SA Pathology, Adelaide, Australia
2Department of Genetics and Molecular Pathology, Centre for Cancer Biology, Adelaide, Australia
3School of Medicine, University of Adelaide, Adelaide, Australia
4SA Pathology, Adelaide, Australia
5Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia
6Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia
7Centre for Cancer Biology, University of South Australia, Adelaide, Australia
8SA Pathology and South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia
9School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia
10School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia
11Centre for Cancer Biology, SA Pathology, University of Adelaide, Adelaide, Australia

Adi J Klil-Drori, MD1,2, Laurent Azoulay, PhD1*, Hui Yin, MSc1*, Michel-Olivier Gratton, MSc2,3*, Michaël Harnois, MSc2,3*, Ines Chamakhi, MD2,4, Robert Delage, MD, MSc, FRCP2,5, Pierre Laneuville, MD, FRCPC2,6, Luigina Mollica, MD, FRCPC, PhD2,7, Harold J. Olney, MD, CM2,8, Lambert Busque, MD2,3 and Sarit E. Assouline, MD MSc1,2

1Jewish General Hospital, Montreal, QC, Canada
2Groupe Québécois de Recherche sur la Leucémie Myéloïde Chronique et Néoplasies Myéloprolifératives (GQR-LMC/NMP), Quebec, Canada
3Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
4Hôpital Sacré-Coeur, Montreal, QC, Canada
5Hôpital de l'Enfant-Jesus, Quebec, QC, Canada
6McGill University Health Centre, Montreal, QC, Canada
7Hôpital Maisonneuve-Rosemont, Montreal, Canada
8CHUM Notre-Dame, Montreal, QC, Canada

Magnus Bjorkholm, MD, PhD1, Hannah Bower2*, Paul W Dickman, MSc PhD2*, Paul C Lambert, PhD2,3*, Martin Höglund, MD, PhD4 and Therese M-L Andersson, PhD2*

1Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
2Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
3Department of Health Sciences, University of Leicester, Leicester, United Kingdom
4Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Verena Sophia Hoffmann, Dr.1*, Michele Baccarani2, Joerg Hasford, MD3*, Doris Lindoerfer1*, Sonja Burgstaller, MD4*, Dubravka Sertic, MD5*, Paul Costeas6*, Jiri Mayer7, Karel Indrak, MD8*, Hele Everaus, MD, PhD9, Perttu Koskenvesa10*, Joelle Guilhot, PhD11, Gabriele Schubert-Fritschle12*, Fausto Castagnetti, MD/PhD13, Francesco Di Raimondo, MD/PhD14, Sandra Lejniece, PhD, MD15*, Laimonas Griskevicius16*, Noortje Thielen, MD, PhD17*, Thomas Sacha18*, Andrzej Hellmann, MD, PhD19, Anna Turkina, Prof., MD20, Andrey Zaritskey, MD21*, Andrija Bogdanovic, MD, PhD, MSc,22*, Zuzana Sninska23*, Irena Zupan24*, Felipe Casado25*, Bengt Simonsson, MD26*, Richard E. Clark, MD27*, Susanne Saussele28, Andreas Hochhaus, MD29 and Ruediger Hehlmann, MD30

1Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität München, Munich, Germany
2Institute of Hematology, University of Bologna, Bologna, Italy
3Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität München, Munich, Germany
4Klinikum Wels-Grieskirchen, Wels, Austria
5Dpt. of Medicine, Division of Hematology, University Hospital Center Zagreb, Zagreb, Croatia
6The Karaiskakio Foundation, Nicosia, Cyprus
7Masaryk University Hospital, Brno, Czech Republic
8Dpt. of Hematology-Oncology, University Hospital, Palacky University, Olomouc, Czech Republic
9Hematology-Oncology, Tartu University Hosptial, Tartu, Estonia
10Helsinki University Central Hospital and Hematology Research Unit, Biomedicum Helsinki, Helsinki, Finland
11INSERM CIC 1402, CHU Poitiers, Poitiers, France
12Munich Cancer Registry, Ludwig-Maximilians-Universität München, Munich, Germany
13Bologna University School of Medicine, Bologna, Italy
14Division of Hematology, Azienda Policlinico-OVE, University of Catania, Catania, Italy
15National Hematology Centre, Riga Eastern Clinical University Hospital, Riga, Latvia
16Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania
17Department of Hematology, VU University Medical Center, Amsterdam, Netherlands
18Dpt. of Hematology, Jagellonian University Hospital, Krakow, Poland
19Dpt. of Hematology and Transplantation, Medical University of Gdansk, Gdansk, Poland
20National Research Center for Hematology, Moscow, Russia
21St. Petersburg State Medical University, St. Petersburg, Russia
22Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia
23Department of Hematology, University Hospital Bratislava, Bratislava, Slovakia
24Department of Hematology, University Clinical Centre Ljubljana, Ljubljana, Slovenia
25Servicio de Hematologia, Hospital Virgen de la Salud, Toledo, Spain
26University of Uppsala, Uppsala, Sweden
27Royal Liverpool University Hospital, Liverpool, United Kingdom
28Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany
29Department of Hematology and Oncology, University Hospital Jena, Jena, Germany
30III. Medizinische Klinik, University of Heidelberg at Mannheim, Mannheim, Germany

Andreas Hochhaus, MD1, Giuseppe Saglio, MD2, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA3, Richard A. Larson, MD4, Lilia Taningco, MSc5*, Weiping Deng5*, Hans D Menssen, MD, PhD6* and Hagop M. Kantarjian, MD7

1Abteilung Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Germany
2University of Turin, Orbassano, Italy
3SA Pathology and South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia
4The University of Chicago, Chicago, IL
5Novartis Pharmaceuticals Corporation, East Hanover, NJ
6Novartis Pharma AG, Basel, Switzerland
7Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Hiroyuki Shimada, MD, PhD1*, Hidemitsu Kurosawa, MD2, Akihiro Watanabe3*, Masaki Ito4*, Chikako Tono5*, Haruko Shima, MD, PhD1*, Yuki Yuza, MD, PhD6*, Hideki Muramatsu, MD, PhD7, Noriko Hotta8*, Masahiko Okada9* and Akihiko Tanizawa10*

1Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan
2Dokkyo Medical University, Tochigi, Japan
3Niigata Cancer Center Hospital, Niigata, Japan
4Fukushima Medical University School of Medicine, Fukushima, Japan
5Aomori Rosai Hospital, Aomori, Japan
6Tokyo Metropolitan Children’s Medical Center, Tokyo, Japan
7Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
8Tokuyama Central Hospital, Tokuyama, Japan
9Nagasaki University School of Medicine, Nagasaki, Japan
10University of Fukui Faculty of Medical Sciences, Fukui, Japan

Eda Tanrikulu Simsek, MD1*, Ahmet Emre Eskazan, MD2, Mahir Cengiz, MD3*, M. Cem Ar, MD, PhD2*, Seda Ekizoglu, PhD4*, Ayse Salihoglu, MD2*, Emine Gulturk, MD2*, Tugrul Elverdi, MD5*, Seniz Ongoren Aydin, MD2*, Ahu Senem Demiroz, MD6*, Ayse Nur Buyru, MD4*, Zafer Baslar, MD2*, Ugur Ozbek, MD, PhD7*, A. Burhan Ferhanoglu, MD8, Yildiz Aydin, MD2*, Nukhet Tuzuner, MD, Professor6* and Teoman Soysal, MD2*

1Department of Internal Medicine, Istanbul University, Cerrahpasa Medicine Faculty, Istanbul, Turkey
2Department of Internal Medicine, Division of Hematology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
3Department of Internal Medicine, Istanbul University, Cerrahpasa Faculty of Medicine, Istanbul, Turkey
4Department of Medical Biology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
5Department of Internal Medicine, Division of Hematology, Van Training and Research Hospital, Van, Turkey
6Department of Pathology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
7Institute of Experimental Medicine, Department of Genetics, Istanbul University, Istanbul, Turkey
8Department of Internal Medicine, Division of Hematology, Koc University, Medical Faculty, Istanbul, Turkey

Jaspal Kaeda, PhD, FRCPath1*, Simone Bonecker2*, Frauke Ringel1*, Michaela Schwarz1*, Bernd Dörken1*, Ilana Zalcberg2* and Philipp Le Coutre, MD1

1Charité - Universitätsmedizin Berlin, Berlin, Germany
2Centro de Transplante de Medula Ossea, Rio de Janeiro, Brazil

Jonathan Douxfils, Pharm.D Ph.D Candidate1*, Hélène Haguet, MSc1*, Christian J. Chatelain, MD2, Carlos Graux, MD PhD2* and Jean-Michel Dogné, Pharm.D Ph.D1*

1Department of Pharmacy, University of Namur, Namur, Belgium
2Department of Hematology, CHU UcL Namur, Mont-Godinne, Belgium

Valentín García-Gutiérrez1*, Dragana  Milojkovic2*, María Luisa Martín Mateos3*, Simone Claudiani4*, Concepcion Boque, PhD5*, Luis Felipe Casado6*, Gloria González7*, Antonio Jiménez8*, Alejandra Martinez Trillos9*, Isabel Mata Vázquez10*, Ángel Ramírez Payer11*, Alberto Álvarez Larran12*, Elena Amutio Díez13*, Abelardo Bárez García, MD14*, Guiomar Bautista Carrascosa15*, Sabela Bobillo Varela16*, Beatriz Cuevas Ruiz17*, Mª Ángeles Fernández Fernández18*, María del Carmen García Garay19*, Pilar Giraldo, MD, PhD20,21, Jose María Guinea de Castro22*, Natalia De Las Heras Rodríguez, MD23*, Nuria Hernanz Soler24*, Ana Iglesias Pérez25*, José Luis López Lorenzo26*, Josep Maria Martí Tutusaus, MD, PhD27*, Rolando Omar Vallansot28*, Fernando Ortega Rivas29*, Jose Manuel Puerta30*, Maria Jose Ramírez Sánchez31*, Esperanza Romero Picos32*, Mario Andrés Romo Collada18*, Ana Rosell Mas33*, Silvana Saavedra Gerosa34*, Ana Sebrango Sadia35*, José Tallón Pérez36*, Sandra Valencia37* and Juan Luis Steegmann, MD38

1Hospital Universitario Ramón y Cajal, Madrid, Spain
2The Hammersmith Hospital, Imperial College, London, United Kingdom
3Servicio de Hematología. Hospital San Pedro de Alcántara.Servicio Extremeño de Salud, Caceres, Spain
4Haematology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
5Insitute Cotele d'Oncologie, Barcelona, Spain
6Servicio de Hematologíay Hematoterapia, Hospital Virgen de la Salud, Toledo., Toledo, Spain
7Hospital Universitario de Canarias, Tenerife, Spain
8Hospital Universitario Carlos Haya, Málaga, Spain
9Hospital Clinic, Barcelona, Spain
10Hospital Costa del Sol, Málaga, Spain
11Hospital Universitario Central de Asturias, Oviedo, Spain
12Hospital del Mar, Barcelona, Spain
13Hospital de Cruces, Vizcaya, Spain
14Department of Hematology, Hospital Nuestra Señora de Sonsoles, Avila, Spain
15Hospital Universitario Puerta de Hierro, Majadahonda, Spain
16Hospital Vall d'Hebron, Barcelona, Spain
17Hospital Universitario de Burgos, Burgos, Spain
18Hospital Meixoeiro, Vigo, Spain
19Hospital Santa Lucia, cartagena, Spain
20Haematology, Miguel Servet University Hospital, Zaragoza, Spain
21ISS, CIBERER, Zaragoza, Spain
22Hospital de Txagorritxu, Vitoria, Spain
23Complejo Hospitalario de Leon, Leon, Spain
24Hospital Virgen de la Candelaria, Santa Cruz de Tenerife, Spain
25Hospital Universitario de Cruces, Bilbao, Spain
26Fundación Jiménez Díaz, Madrid, Spain
27Hospital Mútua de Terrassa, Terrassa, Spain
28Hospital Universitari Joan XXIII, Tarragona, Spain
29Servicio de Hematología., Hospital de Palencia, Palencia, Spain
30Unidad de Gestión Clínica Hematología y Hemoterapia, Hospital Universitario Virgen de las Nieves, Granada, Spain
31Department of Hematology, Hospital de Jerez de la Frontera, Jerez de la Frontera. Cádiz, Spain
32Hospital Arquitecto Marcide, Ferrol, Spain
33Hospital Virgen de la Victoria, Málaga, Spain
34Hospital Santa Creu i Sant Pau, Barcelona, Spain
35Hospital de Torrejón, Madrid, Spain
36Hospital de Jaén, Jaén, Spain
37Hospital de Segovia, Segovia, Spain
38Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, Madrid, Spain

Verena Sophia Hoffmann, Dr.1*, Joerg Hasford, MD2* and Ruediger Hehlmann, MD3

1Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität München, Munich, Germany
2Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität München, Munich, Germany
3Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany

Fiorina Giona, MD1, Giuseppe Saglio, MD2, Michelina Santopietro, MD1*, Giuseppe Menna, MD3*, Grazia Iaria4*, Maria Caterina Putti, MD5*, Concetta Micalizzi, MD6*, Nicola Santoro, MD7*, Saverio Ladogana, MD8*, Rosa Maria Mura, MD9*, Roberta Burnelli, MD10*, Caterina Consarino, MD11*, Carlo Cosmi, MD12*, Maria Luisa Moleti, MD1*, Stefania Varotto, MD5*, Francesca Tucci, MD3*, Mauro Nanni, PhD1*, Daniela Diverio, PhD1*, Andrea Biondi, MD13, Franco Locatelli, Prof, MD, PhD14* and Robin Foà, Prof, MD1

1Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
2Department of Clinical and Biological Sciences, University of Turin at Orbassano, Orbassano, Turin, Italy
3Pediatric Hematology, Pausilipon Hospital, Naples, Italy
4hematology, azienda ospedaliera bianchi-melacrino-morelli, reggio calabria, Italy
5Department of Women’s and Chidren’s Health, University of Padua, Padua, Italy
6Clinical Experimental Hematology Unit, Gaslini Research Institute, Genoa, Italy
7Department of Pediatrics, Policlinico di Bari, Bari, Italy
8Department of Pediatrics, "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, Italy
9Pediatric Hemato-Oncology Unit, Ospedale Regionale per le Microcitemie, Cagliari, Italy
10Pediatric Hemato-Oncology Unit, Sant'Anna Hospital, Ferrara, Italy
11Hemato-Oncology Unit, Pugliese-Ciaccio Hospital, Catanzaro, Italy
12Pediatric Unit, Ospedale di Sassari, Sassari, Italy
13Pediatric Clinic University of Milan Bicocca, Monza, Italy
14Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy

Deborah Meyran1*, Arnaud Petit2*, Joelle Guilhot, PhD3, Meinolf Suttorp4, Eveline S. de Bont5, Chi Kong Li6*, Krzysztof Kalwak7*, Birgitte Lausen8, Srdjana Culic9*, Marie-Françoise Dresse10*, Andrea Biondi, Prof, MD11 and Frédéric Millot12*

1Department of Pediatric Hematology, Robert Debré Hospital, paris, France
2Armand Trousseau Hospital, PARIS, France
3Clinical Investigation Center, INSERM CIC 1402, CHU de Poitiers, Poitiers, France
4Paediatrische Haematologie/Onkologie, Universitatsklinikum Carl Gustav Carus, Dresden, Germany
5Department of Pediatric Oncology/Hematology, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
6Department of Pediatrics, Prince of Wales Hospital, Hong Kong, China
7Department of Pediatric Hematology Oncology and Transplantation, Wroclaw Medical University, Wroclaw, Poland
8Department of Pediatrics, Rigshospitalet, Copenhagen, Denmark
9Department of Pediatric Hematology Oncology Immunology and Medical Genetic, University Hospital, Split, Croatia
10Department of Pediatrics, CHR La Citadelle, Liège, Belgium
11Centro Ricerca Tettamanti, Clinica Pediatrica, Università Milano Bicocca, Osp. San Gerardo/Fondazione MBBM, Monza (MB), Italy
12Inserm CIC 1402, University Hospital, Poitiers, France

Victor M. Rivera1, Susan Branford2*, Franck E. Nicolini3, Justin R. Pritchard1*, Joseph M. Gozgit1*, Wolfgang Kern, MD4, Dragana Milojkovic5*, Simone Claudiani6*, Martin C. Muller7*, Srinivas K Tantravahi8, Michael W. Deininger9, Michael Heinrich10, Simona Soverini11, Michele Baccarani12, Jerald P. Radich13, Elias Jabbour14, Jorge E. Cortes14, Gabriel Etienne15* and Torsten Haferlach4

1ARIAD Pharmaceuticals, Inc., Cambridge, MA
2School of Pharmacy and Medical Science, University of South Australia, Department of Genetics and Molecular Pathology, SA Pathology, Centre for Cancer Biology, School of Medicine and School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia
3Hématologie, Centre Hospitalier Lyon Sud, Pierre Benite, & INSERM, Lyon, France
4MLL Munich Leukemia Laboratory, Munich, Germany
5Department of Haematology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
6Haematology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
7III. Medizinische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany
8Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT
9Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
10Knight Cancer Institute, Oregon Health and Science University, Portland, OR
11Institute of Hematology, S.Orsola-Malpighi University Hospital, Bologna, Italy
12Department of Hematology-Oncology 'L. and A. Seragnoli', S Orsola-Malpighi University Hospital, Bologna, Italy
13Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
14Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
15Institut Bergonié, Bordeaux, France

Juan Manuel Alonso-Dominguez, MD1*, Felipe Casado2*, MariaTeresa Gómez Casares, MD, PhD3*, Ismael Buno4,5*, Francisca Ferrer-Marin6*, Eduardo Anguita, MD, PhD7, Alicia Arenas8*, Rafael Del Orbe, MD9*, Rosa M. Ayala, MD, PhD10, Pilar Llamas, MD11*, Pedro Sanchez-Godoy, MD12*, Carmen Burgaleta, MD13*, Valentín García-Gutierrez14*, Juan Luis Steegmann, MD, PhD15 and Joaquin Martinez-Lopez16*

1Madrid Central Laboratory, BRSalud, Madrid, Spain
2Servicio de Hematologia, Hospital Virgen de la Salud, Toledo, Spain
3Hospital Dr. Negrín, Las Palmas De Gran Canaria, Spain
4Hospital General Universitario Gregorio Marañón, Madrid, Spain
5Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
6Hematology and Medical Oncology Department, Hospital Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB, MURCIA, Spain
7Department of Hematology, Hosp. Clínico U., Madrid, Spain
8Instituto Investigacion Hospital Doce de Octubre, Madrid, Spain
9Biocruces Health Research Institute, Barakaldo, Spain
10Hematology Department, Hospital 12 de Octubre, Madrid, Spain
11Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain
12Hospital Severo Ochoa, Leganes, Spain
13Hematology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain
14Hematology Department, Hospital Ramón y Cajal, Madrid, Spain
15Department of Hematology and IIS-IP, Hospital Universitario de la Princesa, Madrid, Spain
16Hospital-12-de-Octubre, Madrid, Spain

Fausto Castagnetti, MD/PhD1, Gabriele Gugliotta, MD/PhD1*, Massimo Breccia, MD2*, Fabio Stagno, MD, PhD3, Alessandra Iurlo, MD, PhD4*, Francesco Albano, MD5*, Elisabetta Abruzzese, MD6, Bruno Martino, MD7*, Luciano Levato, MD8*, Tamara Intermesoli, MD9*, Patrizia Pregno, MD10*, Giuseppe Rossi, MD11, Filippo Gherlinzoni, MD12, Pietro Leoni, Prof13, Francesco Cavazzini, MD14, Dario Ferrero, MD15*, Emilio Usala, MD16*, Monica Bocchia, MD17*, Mario Tiribelli, MD18*, Enrico Montefusco, MD19*, Simona Sica20*, Claudia Venturi, PhD1*, Simona Soverini1, Michele Cavo, MD1*, Giuliana Alimena, MD2, Giovanni Martinelli, MD1*, Fabrizio Pane, MD21, Giuseppe Saglio, MD22, Michele Baccarani, MD23 and Gianantonio Rosti, MD1*

1Institute of Hematology, S.Orsola-Malpighi University Hospital, Bologna, Italy
2Chair of Hematology, "Sapienza" University, Roma, Italy
3Chair of Hematology, University of Catania, Catania, Italy
4Division of Hematology, IRCCS Maggiore Policlinico Hospital Foundation, Milano, Italy
5Hematology - Dept. of Emergency and Organ Transplantation, University of Bari, Bari, Italy
6Hematology, S. Eugenio Hospital, Roma, Italy
7Az.Osp. Bianchi-Melacrino’-Morelli, Reggio Calabria, Italy
8Section of Hematology, A.O. Pugliese-Ciaccio, Catanzaro, Italy
9Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
10Hematology Unit, AZ OSP. CITTA' DELLA SALUTE E SCIENZA TORINO, TORINO, Italy
11Department of Hematology, Spedali Civili di Brescia, Brescia, Italy
12Unita Operativa Ematologia, Ospedale Ca' Foncello, Treviso, Italy
13Haematology Clinic, Ospedali Riuniti di Ancona, Ancona, Italy
14Hematology Section, Azienda Ospedaliero-Universitaria S. Anna, University of Ferrara, Ferrara, Italy
15Chair of Hematology, Department of Medicine and Experimental Oncology, Torino, Italy
16Hematology Unit, "A.Businco" Hospital, Cagliari, Italy
17Department of Hematology and Transplants, University of Siena, Siena, Italy
18Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy
19Hematology Unity, Sant'Andrea Hospital, Rome, Italy
20Institute of Hematology, Catholic University, Rome, Italy
21Department of Biochemistry and Medical Biotechnologies, Federico II University, Napoli, Italy
22Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy
23Institute of Hematology, University of Bologna, Bologna, Italy

Gwo-Jen Day, Ph.D.1*, Christina Lockwood, Ph.D.2*, Jacqueline E. Payton, MD, PhD3, Geoffrey L. Uy, MD4, Charles Schiffer5, Gerald Feldman, MD, PhD, FACMG6*, Aaron Bossler, MD, PhD7*, Julie Woolworth, Ph.D.8*, Alice S. Mims, MD9, Alba Levitas1*, Krupa Shridhar1*, Sandy Huang1*, Vivian Xiao, Ph.D.1*, Natalie Wu, Ph.D.1*, Michael P. Bates, MD1 and Wendy Wong1*

1Cepheid, Sunnyvale, CA
2University of Washington, Department of Laboratory Medicine, Seattle, WA
3Pathology & Immunology, Washington University School of Medicine, Saint Louis, MO
4Division of Oncology, Washington University School of Medicine, St. Louis, MO
5Wayne State University, Detroit, MI
6Department of Pathology, Wayne State University School of Medicine and Detroit Medical Center University Laboratory, Detroit, MI
7University of Iowa Carver College of Medicine, Molecular Pathology Laboratory, Iowa City, IA
8Medical University of South Carolina, Department of Pathology & Laboratory Medicine, Charleston, SC
9Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH

Simone Claudiani1*, Nikhita Gupta, BSc2*, Ji Soo Baik, BSc2*, Simona Deplano, MD PhD3*, Renuka Palanicawander1*, Gareth Gerrard2*, Alistair G Reid, BSc, PhD1*, Richard M Szydlo, BSc, PhD4*, Dragana Milojkovic3*, Letizia Foroni2* and Jane F. Apperley, MD1,2

1Haematology Department, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
2Centre for Haematology, Imperial College London, London, United Kingdom
3Department of Haematology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
4Centre for Haematology, Imperial College, London, United Kingdom

Jeeyune Bahk, BSc1*, Simone Claudiani, MD2*, Richard M Szydlo, BSc, PhD1*, Sarmad Toma, BSc3*, Faisal Abdillah, BSc3*, Sandra Hing, BSc3*, Simona Deplano, MD PhD2*, Dragana Milojkovic1*, Jane F Apperley, MD1 and Letizia Foroni, MD, PhD1*

1Centre for Haematology, Imperial College, London, United Kingdom
2Department of Haematology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
3Molecular Pathology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom

Binsah Susan George, MBBS1*, Hagop M Kantarjian, MD2, Guillermo Garcia-Manero, MD3, Farhad Ravandi, MD2, Srdan Verstovsek, MD2, Gautam Borthakur, MD2, Nitin Jain, MD2, Sherry Pierce, BSN, BA4*, Koichi Takahashi, MD2, Elias Jabbour2 and Jorge E. Cortes2

1Department of Leukemia, MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
4Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Stuart L. Goldberg, MD1, Yun Su, MD, MPH, MS2*, Candace Gunnarsson, EdD, MA3*, William D Irish, PhD3*, Michael Ryan, MS3*, Mabel Woloj, MD4*, Roxanne Ferdinand, MBBS MRCP MFPM5* and Mark Shapiro, MD6

1Division of Leukemia, John Theurer Cancer Center of Hackensack University Medical Center, Hackensack, NJ
2Outcomes & Evidence, Global Health & Value, Pfizer Inc, New York, NY
3CTI Clinical Trials and Consulting, Cincinnati, OH
4Pfizer Inc, New York, NY
5Haematology Europe/AfME, Pfizer Oncology, Pfizer Ltd, Walton-on-the-Hill, United Kingdom
6Pfizer Inc, Cambridge, MA

Ayala Gover-Proaktor, PhD1*, Oren Pasvolsky, MD2,3*, Pia Raanani, MD2,3, Arnon Nagler, MD, MSc3,4, Saar Shapira, MSc1,3*, Ido Lubin, PhD1,3*, Galit Granot, PhD1* and Avi Leader, MD2,3*

1Felsenstein Medical Research Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel
2Division of Hematology, Davidoff Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel
3Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
4Hematology Division, Chaim Sheba Medical Center and Tel Aviv University, Tel-Hashomer, Ramat-Gan, Israel

*signifies non-member of ASH